1 / 39

Pharmacology: Studying the principles of Drug Action

Pharmacology: Studying the principles of Drug Action. Pharmacokinetics Pharmacodynamics: Drug action Two ways to measure drug effects : Psychopharmacology and Neuropharmacology. Pharmacokinetics. I. Administration II. Absorption & distribution III. Binding and bioavailability

jadyn
Download Presentation

Pharmacology: Studying the principles of Drug Action

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pharmacology: Studying the principles of Drug Action • Pharmacokinetics • Pharmacodynamics: Drug action • Two ways to measure drug effects: Psychopharmacology and Neuropharmacology

  2. Pharmacokinetics • I. Administration • II. Absorption & distribution • III. Binding and bioavailability • IV. Inactivation/Biotransformation (metabolization) • V. Elimination/excretion

  3. I. Administration • A. Dose or dosage • Calculation: Take the desired or prescribed dose (typically in mg/kg) and multiply by the person’s mass (in kg). • Thus, for example, 0.10mg/kg x 60kg = 6 mg dose • Dosage may also be measured in mg/dl of blood plasma, but that is after administration and absorption.

  4. B. Administration methods • 1. Oral • Advantages and disadvantages • Formulations: • Elixirs and syrups • Tablets, capsules, and pills • Historic formulations: • Powder (“Take a powder”) • Cachets • Lozenges and pastilles

  5. B. More administration methods • 2. Parenteral (Injection) • a. Intravenous • b. Intramuscular • c. Subcutaneous • d. Intracranial • e. Epidural • f. Intraperitoneal

  6. B. Administration methods, continued • 3. Respiratory • a. Inhalation v. intranasal (snorting) • b. Smoke (Solids in air suspension) • c. Volatile gases • 4. Transcutaneous or transdermal • 5. Orifice membranes • a. Sublingual • b. Rectal: Suppositories or enemas • c. Vaginal: pessaries or douches (1860) • d. Other orifices: bougies • 6. Topical

  7. Pharmacokinetics • I. Administration • II. Absorption & distribution • Bioavailability • III. Binding • IV. Inactivation/biotransformation (metabolization) • V. Elimination/excretion

  8. II. A. Absorption • 1. Absorption Principles • 2. Absorption Barriers • 3. Absorption mechanics

  9. 1. Absorption Principles • a. General principle: Diffusion, which depends on • i. Solubility (fat and/or water) • ii. Molecular diameter • iii. Volatility (air) • iv. Affinity (Proteins, water [hydrophilic], oil • b. Absorption is influenced by amount of blood flow at the site of administration

  10. 2. Absorption Barriers • Barriers to absorption include • Mucous layers • Membrane pores • Cell walls • First-pass metabolism • Placenta • Blood proteins • Fat isolation • Blood-brain barrier • Exceptions: Area postrema, median eminence of hypothalamus

  11. The blood-brain barrier Glial feet Basement membrane (Pia mater)

  12. Absorption Barriers • To review, barriers to absorption include • Mucous layers • Membrane pores • Cell walls • First pass metabolism • Placenta • Blood proteins • Fat isolation • Blood-brain barrier

  13. 3. Absorption Mechanics • For each drug, water and fat solubility vary. • Relative solubilities depend on • i. pH of the drug • ii. pH of the solution • iii. pKa of the drug • Solubility percentages depend on ionization ratios

  14. Determining the pKa of a drug Solution pH: 0 1 2 3 4 5 6 7 Solution pH: 8 9 10 11 12 13 14

  15. Determining the pKa of a drug % Ionized 2 8 16 26 38 50 62 74 Solution pH: 0 1 2 3 4 5 6 7 % Ionized 84 92 98 99 99 99 99 Solution pH: 8 9 10 11 12 13 14

  16. % Ionization for Darnital

  17. Relative solubilities

  18. Computing Ionization Ratios • According to the Henderson-Hasselbalch equation, the difference between the pH of the solution and the pKa of the drug is the common logarithm of the ratio of ionized to unionized forms of the drug. For acid drugs log(ionized/unionized) = pH - pKa, or ratio of ionized to unionized is 10X / 1, where X = pH – pKa

  19. Computing ionization ratios, 2 For basic drugs, everything is the same except that the ratio reverses: Log(unionized/ionized) = pH – pKa, or Ratio of unionized to ionized is 10X / 1, where X = pH – pKa

  20. Examples Darnital, a weak acid, has a pKa of 5.5. Taken orally, it is in a stomach solution of pH 3.5. pH – pKa = 3.5 – 5.5 = -2 Since Darnital is an acid drug, we use the alphabetical formula ionized/unionized. ionized/unionized = 10-2/1= 1/100 For every 1 molecule of Darnital that is ionized, 100 are unionized. Darnital in the stomach is highly fat soluble.

  21. But look what happens… The highly fat soluble Darnital readily crosses the stomach membranes and enters blood plasma, which has a pH of 7.5 pH – pKa = 7.5 – 5.5 = 2 ionized/unionized = 102/1= 100/1 For every 100 molecules of Darnital that are ionized, only 1 is unionized. Darnital in the blood is not very fat soluble. Darnital will be subject to ion trapping.

  22. Another example Endital, a weak base with a pKa of 7.5 is dissolved in the stomach, pH 3.5 pH – pKa = 3.5 – 7.5 = -4 Since Endital is a base drug, we use the ratio backwards: unionized/ionized. unionized/ionized = 10-4/1= 1/10,000 In the stomach, Endital will be mostly ionized, and not very fat soluble.

  23. But… If we inject Endital intravenously into the blood, with a pH of 7.5, pH – pKa = 7.5 – 7.5 = 0 unionized/ionized = 100 = 1/1 In the blood, Endital will be equally ionized and unionized. Half of the molecules of Endital will be fat soluble, and will readily leave the blood and enter the brain. A dynamic equilibrium follows.

  24. An oddity Caffeine is a base drug, but it has a pKa of 0.5 pH – pKa = 3.5 – 0.5 = 3 Since caffeine is a base drug, we use the ratio backwards: unionized/ionized. unionized/ionized = 103/1= 1000/1 In the stomach, caffeine will be mostly unionized, and fat soluble! In the blood, caffeine will be even more unionized and fat soluble: pH – pKa = 7.5 – 0.5 = 7, ratio = 107/1= 10,000,000/1. Caffeine is a 600 pound gorilla.

  25. 2b. Distribution • The generalized distribution of a drug throughout the body controls the movement of a drug by its effect on ionization ratios • Distribution also controls how long a drug acts and how intense are its effects • Generalized distribution of a drug accounts for most of the side effects produced • Is there a magic bullet?

  26. Mechanisms of distribution • Blood circulation: The crucial minute • But blood flow is greater to crucial organs than to muscle, skin, or bone. • Blood circulation is the main factor affecting bioavailability. • Lymphatic circulation • Depot binding • CSF circulation: The ventricular system

  27. Distribution half-life and therapeutic levels Distribution half-life: the amount of time it takes for half of the drug to be distributed throughout the body Therapeutic level: the minimum amount of the distributed drug necessary for the main effect.

  28. Resultant Elimination Distribution Half-life curves Blood level 2 4 6 8 10 12 14 Time in hours

  29. Pharmacokinetics • 1. Administration • 2. Absorption and distribution • 3. Binding and bioavailability • 4. Inactivation/biotransformation • 5. Elimination/excretion

  30. Pharmacokinetics • 1. Administration • 2. Absorption • 3. Distribution and bioavailability • 4. Biotransformation and elimination

  31. 4. Elimination • Routes of elimination: All body secretions • Air • Perspiration, saliva, milk • Bile • Urine • Regurgitation • Kidney action • Liver enzyme activity: Generalized

  32. Enzyme activity • Enzymes in gi tract cells • Buspirone and grapefruit juice • Enzymes in hepatocytes • Cytochrome P-450 families: CYP1-3 • Cross-tolerance • Biotransformation • Type I and type II • Metabolites are larger, less fat soluble, more water soluble • Metabolite activity is usually lowered

  33. Elimination phenomena • Elimination half-life and side effects • Tolerance and Mithradatism • Metabolic tolerance or enzyme-induction tolerance • Cross-tolerance: Carbamazepine and fluoxetine (Tegretol and Prozac) • Cellular-adaptive tolerance • Behavioral conditioning and state-dependent tolerance

  34. Tolerance More tolerance phenomena • Tachyphylaxis • Acute tolerance: The BAC curve • Mixed tolerance • Reverse tolerance or sensitization and potentiation: Fluvoxamine and clozapine; Zantac or Tagamet and alcohol

  35. Balancing distribution and elimination • Elimination half-life and hangovers • Accumulation dosing: The 6 half-life rule and regular dosing • Steady-state dosing • Therapeutic drug monitoring (TDM)

  36. Accumulation dosing Plasma level, mg/dl 50 100 150 200250 300 350 A 1 B 2 C 3 D 4 E 5 F 6 G 7 Letters = doses; numbers = half-lives

  37. Dependence and Addiction • Physiological dependence: The abstinence syndrome • Cross-dependence • Habituation and conditioning • Addiction and behavioral reinforcement • Positive reinforcement • Negative reinforcement

  38. Automatic enemas

  39. Nineteenth century inhaler

More Related